Currently, numerous studies have shown that EGFR is overexpressed or abnormally expressed in many different types of tumors [4,5,6,7], including in more than 80% of non-small cell lung cancers (NSCLC). This evidence concerns the gene EGFR and non-small cell lung carcinoma.